Quantum Pharmaceutical

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Quantum Pharmaceutical is a manufacturer and supplier of unlicensed medicines and Special Obtain products based in Burnopfield, County Durham.

History[edit]

Quantum was formed in 2004, and began trading with a small team of pharmacists and technicians at Tyne Metropolitan College on North Tyneside and focused on selling special supplies to retail and wholesale pharmacy. In 2006 the company expanded and moved to Burnopfield in County Durham.

In 2011, Quantum Pharmaceutical acquired Total Medication Management Services Ltd, a distributor of medication in Biodose to various sectors.

In 2012 the firm acquired UL Medicines, a supplier of unlicensed pharmaceutical imports and batch made specials to hospitals. In that year the company also bought a stake in Protomed Ltd, the developer of Biodose, which is a monitored dosage system for patients in care homes and in care at home.

Products and Services[edit]

  • Specials: Non-licensed medicines manufactured or procured to suit the needs of individual patients, including:
    • alternative delivery mechanisms
    • non-standard dosages
    • unusual formulations
    • preservative / additive free formulations
    • overseas licensed pharmaceuticals
    • discontinued licensed products
    • medium / long term unavailable products
  • Special Obtains
  • Aseptic products
  • Biodose: a company-proprietary dosage management system

Congroversy[edit]

In June 2013 the Daily Telegraph infiltrated reporters into the annual Pharmacy Congress to investigate malpractice in the market for Specials.[1] These products are generally individually priced. It was alleged that the company was prepared to offer backhanders in various ways. In particular it was alleged that the company could supply generic drugs free of charge in return for the right to supply a chain of pharmacies with special drugs.

In December 2013 it was fined more than £380,000 by the Office of Fair Trading over a cartel arrangement in which it carved up some of a multimillion-pound market in prescription drugs for care homes with Lloyds Pharmacy.[2]

References[edit]

  1. ^ "Pharmaceutical scandal: 'You pay us £300. However, your invoice will say £600. So £300 stays with you.'". Daily Telegraph. 20 June 2013. Retrieved 13 December 2013. 
  2. ^ "Drug firm fined for care homes 'cartel'". Health Service Journal. 13 December 2013. Retrieved 13 December 2013. 

External links[edit]